These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 11548736)

  • 1. Olanzapine and clozapine: comparative effects on motor function in hallucinating PD patients.
    Leucht S
    Neurology; 2001 Aug; 57(4):747. PubMed ID: 11548736
    [No Abstract]   [Full Text] [Related]  

  • 2. Olanzapine and clozapine: comparative effects on motor function in hallucinating PD patients.
    Sa DS; Lang AE
    Neurology; 2001 Aug; 57(4):747. PubMed ID: 11524507
    [No Abstract]   [Full Text] [Related]  

  • 3. Olanzapine and clozapine: comparative effects on motor function in hallucinating PD patients.
    Goetz CG; Blasucci LM; Leurgans S; Pappert EJ
    Neurology; 2000 Sep; 55(6):789-94. PubMed ID: 10993997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deterioration of parkinsonian symptoms following treatment of dopaminergic hallucinosis with olanzapine.
    Rudolf J; Ghaemi M; Schmülling S
    Eur Psychiatry; 1999 Oct; 14(6):356-7. PubMed ID: 10572371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leucopenia induced by low dose clozapine in Parkinson's disease recedes shortly after drug withdrawal. Clinical case descriptions with commentary on switch-over to olanzapine.
    Onofrj M; Thomas A; Bonanni L; Iacono D; Gambi F
    Neurol Sci; 2000 Aug; 21(4):209-15. PubMed ID: 11214659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olanzapine for psychosis in Parkinson's disease.
    Sa DS; Lang AE
    Neurology; 2001 Jun; 56(12):1781. PubMed ID: 11425961
    [No Abstract]   [Full Text] [Related]  

  • 7. Olanzapine treatment for dopaminergic-induced hallucinations.
    Ondo WG; Levy JK; Vuong KD; Hunter C; Jankovic J
    Mov Disord; 2002 Sep; 17(5):1031-5. PubMed ID: 12360554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine to olanzapine.
    Millson RC; Delva NJ
    Am J Psychiatry; 1999 Jul; 156(7):1121. PubMed ID: 10401476
    [No Abstract]   [Full Text] [Related]  

  • 9. Substituting clozapine for olanzapine in psychiatrically stable Parkinson's disease patients: results of an open label pilot study.
    Friedman JH; Goldstein S; Jacques C
    Clin Neuropharmacol; 1998; 21(5):285-8. PubMed ID: 9789708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Worsening of motor features of parkinsonism with olanzapine.
    Molho ES; Factor SA
    Mov Disord; 1999 Nov; 14(6):1014-6. PubMed ID: 10584679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of risperidone and olanzapine on the indications for clozapine.
    Ganguli R; Brar JS
    Psychopharmacol Bull; 1998; 34(1):83-7. PubMed ID: 9564203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical antipsychotics.
    Jefferson AM; Markowitz JS; Brewerton TD
    J Am Acad Child Adolesc Psychiatry; 1998 Dec; 37(12):1243-4. PubMed ID: 9847493
    [No Abstract]   [Full Text] [Related]  

  • 13. Uncommon side effects associated with olanzapine. A case report.
    Farooque R
    Pharmacopsychiatry; 2003; 36(2):83. PubMed ID: 12734767
    [No Abstract]   [Full Text] [Related]  

  • 14. Riluzole and olanzapine in Huntington's disease.
    Bonelli RM; Niederwieser G; Diez J; Költringer P
    Eur J Neurol; 2002 Mar; 9(2):183-4. PubMed ID: 11882065
    [No Abstract]   [Full Text] [Related]  

  • 15. [The use of clozapine and levodopa for the treatment of persistent visual hallucinations and parkinsonism in Lewy body dementia].
    Archie A; Persoons P; Vandenbulcke M
    Tijdschr Psychiatr; 2013; 55(4):287-91. PubMed ID: 23595844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Switching antipsychotic medications.
    Weiden PJ; Aquila R; Dalheim L; Standard JM
    J Clin Psychiatry; 1997; 58 Suppl 10():63-72. PubMed ID: 9265919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine for the treatment of psychosis in patients with Parkinson's disease and dementia.
    Marsh L; Lyketsos C; Reich SG
    Psychosomatics; 2001; 42(6):477-81. PubMed ID: 11815682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent priapism during treatment with clozapine and olanzapine.
    Compton MT; Saldivia A; Berry SA
    Am J Psychiatry; 2000 Apr; 157(4):659. PubMed ID: 10777416
    [No Abstract]   [Full Text] [Related]  

  • 19. [The role of olanzapine in Parkinsonian dopaminergic psychosis].
    Durán-Ferreras E; Chacón-Peña JR; Durán-Quintana JA
    Rev Neurol; 2002 Oct 1-15; 35(7):691-6. PubMed ID: 12389159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of olanzapine, as needed, to treat acute agitation in juveniles.
    Sheikh RM; Ahmed K
    J Child Adolesc Psychopharmacol; 2002; 12(1):71-3. PubMed ID: 12014599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.